Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions.

The complete nucleotide sequence of a hepatitis C virus derived from plasma of a human carrier in Japan was determined. The cDNA of the isolate (HC-J6) contained 9481 nucleotides and an additional T stretch of 30 to 108 nucleotides at the 3' end, and had one large open reading frame coding for a polyprotein of 3033 amino acids. It differed by 31.8 to 32.1% in the nucleotide sequence and by 27.4 to 27.7% in the amino acid sequence from an American isolate and two Japanese isolates previously reported. Among these four isolates, the 5' non-coding region of 329 to 341 nucleotides was well conserved (greater than 93% identity), whereas the 3' non-coding region of 39 to 45 nucleotides (T stretches not included) was more variable (greater than 30% identity). An excellent degree of conservation of the 5' non-coding region would reflect its pivotal role in replication, and primers deduced from this region could be applied for the sensitive and specific detection of viral RNA by polymerase chain reaction. Due to a high degree of similarity in the amino acid sequence of the putative core protein (greater than 90%), antigen probes deduced from it would be suitable for the serological diagnosis of HCV infection. Low sequence similarity in the putative envelope protein (greater than 53% identity), however, would have to be taken into account in considering the immunoprophylaxis of HCV infection.

[1]  P. Barr,et al.  Genetic organization and diversity of the hepatitis C virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  H. Okayama,et al.  Structure and organization of the hepatitis C virus genome isolated from human carriers , 1991, Journal of virology.

[3]  Matthew J. Brauer,et al.  Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[4]  M. Houghton,et al.  Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay , 1991, The Lancet.

[5]  T. Sugimura,et al.  Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. Houghton,et al.  The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. , 1990, The Journal of general virology.

[7]  N. Kato,et al.  A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus. , 1990, Biochemical and biophysical research communications.

[8]  H. Okamoto,et al.  Enzyme-linked immunosorbent assay for antibodies against the capsid protein of hepatitis C virus with a synthetic oligopeptide. , 1990, The Japanese journal of experimental medicine.

[9]  S. Mishiro,et al.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. , 1990, The Japanese journal of experimental medicine.

[10]  T. Dewar.  Non-A, non-B hepatitis. , 1990, The Western journal of medicine.

[11]  M. Hulst,et al.  Molecular cloning and nucleotide sequence of hog cholera virus strain Brescia and mapping of the genomic region encoding envelope protein E1. , 1990, Virology.

[12]  H. Okamoto,et al.  The 5'-terminal sequence of the hepatitis C virus genome. , 1990, The Japanese journal of experimental medicine.

[13]  H J Alter,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. , 1990, Science.

[14]  H. Reesink,et al.  Infectivity of blood seropositive for hepatitis C virus antibodies , 1990, The Lancet.

[15]  R. Purcell,et al.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[16]  R. Purcell,et al.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. , 1989, The New England journal of medicine.

[17]  J. Riechmann,et al.  Homologous potyvirus and flavivirus proteins belonging to a superfamily of helicase-like proteins. , 1989, Gene.

[18]  M. Buti,et al.  HEPATITIS C VIRUS ANTIBODIES AMONG RISK GROUPS IN SPAIN , 1989, The Lancet.

[19]  W. Gilbert,et al.  One-sided polymerase chain reaction: the amplification of cDNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[20]  H. Thiel,et al.  Molecular cloning and nucleotide sequence of the genome of hog cholera virus. , 1989, Virology.

[21]  R. Fletterick,et al.  Detection of a trypsin-like serine protease domain in flaviviruses and pestiviruses. , 1989, Virology.

[22]  M. Houghton,et al.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. , 1989, Science.

[23]  Jules L. Dienstag,et al.  An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis , 1989 .

[24]  D. Anderson,et al.  Molecular cloning and nucleotide sequence of the pestivirus bovine viral diarrhea virus. , 1988, Virology.

[25]  R. Redfield,et al.  Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. , 1986, Science.

[26]  W. Fitch,et al.  Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. , 1986, Science.

[27]  P. Argos,et al.  Primary structural comparison of RNA-dependent polymerases from plant, animal and bacterial viruses. , 1984, Nucleic acids research.

[28]  F. Sanger,et al.  DNA sequencing with chain-terminating inhibitors. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Purcell,et al.  Non-A, non-B hepatitis. , 1976, Annual review of medicine.

[30]  G. Grady,et al.  Long-incubation post-transfusion hepatitis without serological evidence of exposure to hepatitis-B virus. , 1974, Lancet.

[31]  C. Rice,et al.  Flavivirus genome organization, expression, and replication. , 1990, Annual review of microbiology.

[32]  J. Holland,et al.  Rapid evolution of RNA viruses. , 1987, Annual review of microbiology.

[33]  F. Heinz,et al.  Epitope mapping of flavivirus glycoproteins. , 1986, Advances in virus research.

[34]  J. Dienstag.  Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. , 1983, Gastroenterology.

[35]  R. Purcell,et al.  Transfusion‐associated hepatitis not due to viral hepatitis type A or B † , 1975, The New England journal of medicine.